Clinical Trial Update: Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)

View source ↗

Summary

A clinical trial assessing pharmacovigilance reporting of cardiovascular adverse events associated with antineoplastic agents; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cardiovascular Disease

Snippet

Sponsor: The First Affiliated Hospital of Xinxiang Medical College | Conditions: Cardiovascular Diseases, Cardiac Diseases | Status: NOT_YET_RECRUITING